Certain Hydrodermabrasion Systems and Components Thereof II; Notice of a Commission Determination Not To Review an Initial Determination Granting Complainant's Unopposed Motion To Terminate Without Prejudice the Investigation Based Upon Withdrawal of the Complaint
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Issuing agencies
Abstract
Notice is hereby given that the U.S. International Trade Commission ("Commission") has determined not to review an initial determination ("ID") (Order No. 15) of the presiding administrative law judge ("ALJ") granting complainant's unopposed motion to, inter alia, terminate without prejudice the investigation based upon withdrawal of the complaint.
Full Text
<html>
<head>
<title>Federal Register, Volume 90 Issue 51 (Tuesday, March 18, 2025)</title>
</head>
<body><pre>
[Federal Register Volume 90, Number 51 (Tuesday, March 18, 2025)]
[Notices]
[Pages 12567-12568]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2025-04317]
=======================================================================
-----------------------------------------------------------------------
INTERNATIONAL TRADE COMMISSION
[Investigation No. 337-TA-1416]
Certain Hydrodermabrasion Systems and Components Thereof II;
Notice of a Commission Determination Not To Review an Initial
Determination Granting Complainant's Unopposed Motion To Terminate
Without Prejudice the Investigation Based Upon Withdrawal of the
Complaint
AGENCY: U.S. International Trade Commission.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: Notice is hereby given that the U.S. International Trade
Commission (``Commission'') has determined not to review an initial
determination (``ID'') (Order No. 15) of the presiding administrative
law judge (``ALJ'') granting complainant's unopposed motion to, inter
alia, terminate without prejudice the investigation based upon
withdrawal of the complaint.
FOR FURTHER INFORMATION CONTACT: Michael Liberman, Esq., Office of the
General Counsel, U.S. International Trade Commission, 500 E Street SW,
Washington, DC 20436, telephone (202) 205-3115. Copies of non-
confidential documents filed in connection with this investigation may
be viewed on the Commission's electronic docket (EDIS) at <a href="https://edis.usitc.gov">https://edis.usitc.gov</a>. For help accessing EDIS, please email
<a href="/cdn-cgi/l/email-protection#5510111c06661d3039251520263c21367b323a23"><span class="__cf_email__" data-cfemail="11545558422259747d615164627865723f767e67">[email protected]</span></a>. General information concerning the Commission may
also be obtained by accessing its internet server at <a href="https://www.usitc.gov">https://www.usitc.gov</a>. Hearing-impaired persons are advised that information on
this matter can be obtained by contacting the Commission's TDD
terminal, telephone (202) 205-1810.
SUPPLEMENTARY INFORMATION: The Commission instituted this investigation
on September 10, 2024, based on a complaint filed on behalf of
HydraFacial LLC f/k/a Edge Systems LLC of Long Beach, California
(``HydraFacial,'' or ``Complainant''). 89 FR 73446-47 (Sept. 10, 2024).
The complaint, as supplemented, alleges violations of section 337 based
upon the importation into the United States, the sale for importation,
and the sale within the United States after importation of certain
hydrodermabrasion systems and components thereof by reason of the
infringement of claims 1-12, 14-20, 22-26, 28-37, and 39-45 of U.S.
Patent No. 11,865,287 and claims 1-8 and 11-16 of U.S. Patent No.
9,550,052. The Commission's notice of investigation
[[Page 12568]]
named as respondents Aesthetics Management Partners of Cordova,
Tennessee (``AMP''); Sinclair Pharma U.S. Inc. of Irvine, California
and Sinclair Pharma Limited of London, United Kingdom (collectively,
``Sinclair''); EMA Aesthetics, Ltd. of Dublin, Ireland; (``EMA''); and
Huadong Medicine Co., Ltd. of Hangzhou, Zhejiang, China (``HMC,'' and
with AMP, Sinclair, EMA, and HMC, collectively, ``Respondents''). The
Office of Unfair Import Investigations is not a party in this
investigation.
On September 26, 2024, the ALJ issued an initial determination
(Order No. 5) setting the target date in this investigation for April
10, 2026, with the initial determination on violation due no later than
December 10, 2025. On October 2, 2024, HydraFacial filed a petition for
review of Order No. 5. On October 9, 2024, Respondents filed an
opposition to HydraFacial's petition (``Opposition'').\1\
---------------------------------------------------------------------------
\1\ Respondents noted that respondents H.R. Meditech and
Advanced Aesthetics Services LLC did not appear in this
investigation and did not participate in Respondents' Opposition.
See Respondents' Opposition at 1 n. 1.
---------------------------------------------------------------------------
On October 28, 2024, the Commission issued a notice of its
determination not to review Order No. 5. See also Commission
Determination to Deny Complainant's Petition for Reconsideration of the
Commission's Decision Not to Review an Initial Determination Setting a
Target Date (Nov. 21, 2024).
On February 18, 2025, complainant HydraFacial filed an unopposed
motion to, inter alia, terminate this investigation based on withdrawal
of the complaint (``Motion''). Mot. at 1.
Complainant certifies that it conferred with Respondents with
respect to this Motion. Id. Complainant reports that Respondents do not
oppose the Motion and waived the two-business day requirement. Id.
On February 19, 2025, the ALJ issued the subject ID. The ID granted
the Motion for good cause shown and because no party to this
investigation opposes. ID at 2.
No petitions for review were filed. The Commission has determined
not to review the ID.
The Commission vote for this determination took place on March 11,
2025.
The authority for the Commission's determination is contained in
section 337 of the Tariff Act of 1930, as amended (19 U.S.C. 1337), and
in Part 210 of the Commission's Rules of Practice and Procedure (19 CFR
part 210).
By order of the Commission.
Issued: March 12, 2025.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2025-04317 Filed 3-17-25; 8:45 am]
BILLING CODE 7020-02-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.